Plasma DNA microsatellites as tumor-specific markers and indicators of tumor progression in melanoma patients

Cancer Research

Volumn 59, Issue 7, 1999, Pages 1567-1571

  Fujiwara, Yoshiyuki ^a   Chi, Dorcas D J ^a   Wang, HeJing ^b   Keleman, Pond ^a   Morton, Donald L ^a   Turner, Roderick ^c   Hoon, Dave S B ^a  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAINT JOHN'S HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSATELLITE DNA; TUMOR MARKER;

ARTICLE; CANCER GROWTH; CHROMOSOME MAP; CONTROLLED STUDY; DNA DETERMINATION; HETEROZYGOSITY LOSS; HUMAN; MAJOR CLINICAL STUDY; MELANOMA; PREDICTION; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; BIOLOGICAL MARKERS; FEMALE; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MELANOMA; MICROSATELLITE REPEATS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0033119008     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Fearon, E. R., and Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell, 61: 759-767, 1990.
2. Friend, S. H., Bernards, R., Rogelj, S., Weinberg, R. A., Rapaport, J. M. Albert, D. M., and Dryja, T. P. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature (Lond.), 323: 643-646, 1986.
3. Call, K. M., Glaser, T., Ito, C. Y., Buckler, A. J., Pelletier, J., Haber, D. A., Rose, E. A., Kral, A., Yeger, H., Lewis, W. H., et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell, 60: 509-520, 1990.
4. Kinzler, K., Nilbert, M. C., Su, L. K., Vogelstein, B., Bryan, T. M., Levy, D. B., Smith, K. J., Preisinger, A. C., Hedge, P., McKechnie, D., et al. Identification of FAP locus genes from chromosome 5q21. Science (Washington DC), 253: 661-665, 1991.
5. Rouleau, G. A., Merel, P., Lutchman, M., Sanson, M., Zucman, J., Marineau, C., Hoang-Xuan, K., Demczuk, S., Desmaze, C., Plougastel, B., et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature (Lond.), 363: 515-521, 1993.
6. Latif, F., Tory, K., Gnarra, J., Yao, M., Duh, F. M., Orcutt, M. L., Stackhouse, T., Kuzmin, I., Modi, W., Geil, L., et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science (Washington DC), 260: 1317-1320, 1993.
7. rd, Johnson, B. E., and Skolnick, M. H. A cell cycle regulator potentially involved in genesis of many tumor types. Science (Washington DC), 264: 436-440, 1994.
8. Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W. K., Lin, H., Ligon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., Frye, C., Hu, R., Swedlund, B., Teng, D. H., and Tavitgian, S. V. Identification of a candidate tumor suppressor gene. MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet., 15: 356-362, 1997.
9. Hahn, S. A., Schutte, M., Hoque, A. T., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., and Kern, S. E. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science (Washington DC), 271: 350-353, 1996.
10. Harada, Y., Katagiri, T., Ito, I., Akiyama, F., Sakamoto, G., Kasumi, F., Nakamura, Y., and Emi, M. Genetic studies of 457 breast cancers. Clinicopathologic parameters compared with genetic alternation. Cancer (Phila.), 74: 2281-2286, 1994.
11. Mao, L., Schoenberg, M. P., Scichitano, M., Erozan, Y. S., Merlo, A., Schwab, D., and Sidransky, D. Molecular detection of primary bladder cancer by microsatellite analysis. Science (Washington DC), 271: 659-662, 1996.
12. Kuroki, T., Fujiwara, Y., Tscuchiya, E., Nakamori, S., Imaoka, S., Kanematsu, T., and Nakamura, Y. Accumulation of genetic changes during development and progression of hepatocellular carcinoma. Genes Chromosomes Cancer, 13: 163-167, 1995.
13. Healy, E., Rehman, I., Angus, B., and Rees, L. Loss of heterozygosity in sporadic primary cutaneous melanoma. Genes Chromosomes Cancer, 12: 152-156, 1995.
14. Jen, J., Kim, H., Piantadosi, S., Liu, Z. F., Levitt, R. C., Sistonen, P., Kinzler, K. W., Vogelstein, B., and Hamilton, S. R. Allelic loss of chromosome 18q and prognosis in colorectal cancer. N. Engl. J. Med., 331: 213-221, 1994.
15. Mao, L., Lee, D. J., Tockman, M. S., Erozan, Y. S., Askin, F., and Sidransky, D. Microsatellite alternations as clonal markers for the detection of human cancer. Proc. Natl. Acad. Sci. USA, 91: 9871-9875, 1994.
16. Healy, E., Belgaid, C., Takata, M., Harrison, D., Zhu, N. W., Burd, D. A., Rigby, H. S., Matthews, J. N., and Rees, J. L. Prognostic significant of allelic losses in primary melanoma. Oncogene, 16: 2213-2218, 1998.
17. Stroun, M., Anker, P., Lyautey, J., Lederrey, C., and Maurice, P. A. Isolation and characterization of DNA from the plasma of cancer patients. Eur. J. Cancer Clin. Oncol., 23: 707-712, 1987.
18. Stroun, M., Anker, P., Maurice, P., Lyautey, J., Lederrey, C., and Beljanski, M. Neoplastic characteristics of the DNA found in the plasma of cancer patients. Oncology. 46: 318-322, 1989.
19. Chen, X. Q., Stroun, M., Magnenat, J. L., Nicod, L. P., Kurt, A. M., Lyautey, J., Lederrey, C., and Anker, P. Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat. Med., 2: 1033-1035, 1996.
20. Nawroz, H., Koch, W., Anker, P., Stroun, M., and Sidransky, D. Microsatellite alterations in serum DNA of head and neck cancer patients. Nat. Med., 2: 1035-1037, 1996.
21. Anker, P., Lefort, F., Vasioukhin, V., Lyautey, J., Lederrey, C., Chen, X. Q., Stroun, M., Mulcahy, H. E., and Farthing, M. J. K-ras mutations are found in DNA extraction from the plasma of patients with colorectal cancer. Gastroenterology, 112: 1114-1120, 1997.
22. Yamada, T., Nakamori, S., Ohzato, H., Oshima, S., Aoki, T., Higaki, N., Sugimoto, K., Akagi, K., Fujiwara, Y., Nishisho, I., Sakon, M., Gotoh, M., and Monden, M. Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features. Clin. Cancer Res., 4: 1527-1532, 1998.
23. Leon, S. A., Shapiro, D. M., Sklaroff, D. M., and Yaros, M. J. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res., 37: 646-650, 1977.
24. Morton, D. L., Wong, J. H., Kirkwood, J. M., and Parker, R. G. Malignant melanoma. In: J. F. Holland, E. Frei, R. C. Bast, Jr., D. Kufe, D. L. Morton, and R. R. Weichselbaum (eds.). Cancer Medicine, pp.1793-1824. Philadelphia: Lea and Febigcr, 1993.
25. Balch, C. M., Soong, S-J., Shaw, H. M., Urist, M. M., and McCarthy, W. H. An analysis of prognostic factors in 8500 patients with cutaneous melanoma. In: C. M. Balch, A. N. Houghton, G. W. Milton, A. S. Sober, and S-J. Soong (eds.), Cutaneous Melanoma, pp. 165-187, Philadelphia: J. B. Lippincott, 1992.
26. Buzaid, A. C., Ross, M. I., Balch, C. M., Soong, S., McCarthy, W. H., Tinoco, L., Mansfield, P., Lee, J. E., Bedikian, A., Eton, O., Plager, C., Papadopoulos, N., Legha, S. S., and Benjamin, R. S. Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system. J Clin. Oncol, 15: 1039-1051, 1997.
27. Barnhill, R. L., and Mihm, M. C. Histopathology of malignant melanoma and its precursor lesions. In: C. M. Balch, A. N. Houghton, G. W. Milton, A. S. Sober, and S-J. Soong (eds.), Cutaneous Melanoma, pp. 234-263. Philadelphia: J. B. Lippincott, 1992.
28. Essner, R., Kuo, C. T., Wang, H., Wen, D. R., Turner, R. R., Nguyen, T., and Hoon, D. S. B. Prognostic implication of p53 overexpression in cutaneous melanoma from sun-exposed and nonexpressed sites. Cancer (Phila.), 82: 309-316, 1998.
29. Holland, E. A., Beaton, S. C., Edwards, B. G., Kefford, R. F., and Mann, G. J. Loss of heterozygosity and homozygosity deletions on 9p21-p22 in melanoma. Oncogene, 9: 1361-1365, 1994.
30. Hussussian, C. J., Struewing, J. P., Goldstein, A. M., Higgins, P. A., Ally, D. S., Sheahan, M. D., Clark, W. H., Jr., Tucker, M. A., and Dracopoli, N. C. Germline p16 mutations in familial melanoma. Nat. Genet., 8: 15-21, 1994.
31. Nobori, T., Miura, K., Wu, D., Louis, A., Takabayashi, K., and Carson, D. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature (Lond.), 368: 753-756, 1994.
32. Dracopoli, N. C., Harnett, P., Bale, S. J., Stanger, B. Z., Tucker, M. A., Housman, D. E., and Kefford, R. F. Loss of allcles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression. Proc. Natl. Acad. Sci. USA, 86: 4614-4618, 1989.
33. Millikin, D., Meese, E., Vogelstein, B., Witkowski, C., and Trent, J. Loss of heterozygosity for loci on the long arm of chromosome 6 in human malignant melanoma. Cancer Res., 51: 5449-5453, 1991.
34. Herbst, R. A., Weiss, J., Ehnis, A., Cavenee, W. K., and Arden, K. C. Loss of heterozygosity for 10q22-qter in malignant melanoma progression. Cancer Res., 54: 3111-3114, 1994.
35. Herbst, R. A., Larson, A., Weiss, J., Cavenee, W. K., Hampton, G. M., and Arden, K. C. A defined region of loss of heterozygosity at 11q23 in cutaneous malignant melanoma. Cancer Res., 55: 2494-2496, 1995
36. Fujiwara, Y., Emi, M., Ohata, H., Kato, Y., Nakajima, T., Mori, T., and Nakamura, Y. Evidence for the presence of two tumor suppressor genes on chromosome 8p for colorectal carcinoma. Cancer Res., 53: 1172-1174, 1993.
37. Fleiss, J. L. Statistical Methods for Rates and Proportions, Chapter 13, Measurement of inter-rate agreement, pp. 212-236. New York: John Wiley and Sons, 1981.
38. Hoon, D. S. B., Wang, Y., Dale, P. S., Conrad, A. J., Schmid, P., Garrison, D., Kuo, C., Foshag, L. J., Nizze, A. J., and Morton, D. L. Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. J. Clin. Oncol., 13: 2109-2116, 1995.
39. Sarantou, T., Chi, D. D., Garrison, D. A., Conrad, A. J., Schmid, P., Morton, D. L., and Hoon, D. S. B. Melanoma-associated antigens as messenger RNA detection markers for melanoma. Cancer Res., 57: 1371-1376, 1997.
40. Shapiro, D., Chakrabarty, M., Cohn, E. M., and Leon, S. A. Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease. Cancer (Phila.), 51: 2116-2120, 1983.
41. van den Berg, A., Dijkhuizen, T., Draaijers, T. G., Hulsbeek, M. M., Maher, E. R., van den Berg, E., Storkel, S., and Buys, C. H. Analysis of multiple renal cell adenomas and carcinomas suggests allelic loss at 3p21 to be a prerequisite for malignant development. Genes Chromosomes Cancer, 19: 228-232, 1997.